All In Biotech

Free tool

FAERS Monitor: Desvenlafaxine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204150 or its brand name (Desvenlafaxine, Desvenlafaxine). Reports on generic versions are filed under their own applications.

Reports

5,261

Serious

3,264

62% of reports

Hospitalization

1,369

Death reported

457

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective718
  • off label use369
  • nausea351
  • toxicity to various agents304
  • headache299
  • anxiety297
  • fatigue284
  • depression245
  • dizziness234
  • completed suicide214
  • drug interaction208
  • overdose205
  • pain186
  • insomnia178
  • suicidal ideation176

Reports by year received

View as table
YearReports
20084
200911
201043
201128
201268
201361
201436
2015118
201682
2017297
2018249
2019372
2020472
2021492
2022674
2023630
2024578
2025560
2026486

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,898 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (500). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal21410.39.01,788
drug interactionSignal2085.24.6715
depressionSignal2454.33.8625
anxietySignal2974.23.7723
overdoseSignal2053.83.3424
insomniaSignal1782.72.3187
drug ineffectiveSignal7182.22.0487
headache2991.91.7132
dizziness2341.91.797
nausea3511.81.6122
off label use3691.71.5106
fatigue2841.51.342
pain1861.21.17
toxicity to various agents3040.00.01,212,302
suicidal ideation1760.00.0700,173

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.